Osterroth; Frank
Patent Applications and Registrations
Patent applications and USPTO patent grants for Osterroth; Frank.The latest application filed is for "uses of immunoconjugates targeting cd138".
- Osterroth; Frank - Dietzenbach DE
| Patent | Date |
|---|---|
| Uses Of Immunoconjugates Targeting Cd138 App 20190117770 - Schulz; Gregor ; et al. | 2019-04-25 |
| Uses of immunoconjugates targeting CD138 Grant 10,117,932 - Schulz , et al. November 6, 2 | 2018-11-06 |
| Agents for treating disease Grant 9,995,733 - Osterroth , et al. June 12, 2 | 2018-06-12 |
| Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 9,605,066 - Osterroth , et al. March 28, 2 | 2017-03-28 |
| Immunoconjugates Targeting Cd138 And Uses Thereof App 20170081418 - KRAUS; Elmar ; et al. | 2017-03-23 |
| Method for treating psoriasis Grant 9,550,831 - Aigner , et al. January 24, 2 | 2017-01-24 |
| Use of antibodies for detection of IL-10 Grant 9,540,436 - Osterroth , et al. January 10, 2 | 2017-01-10 |
| Agent for treating disease Grant 9,512,226 - Germer , et al. December 6, 2 | 2016-12-06 |
| Methods and agents for improving targeting of CD138 expressing tumor cells Grant 9,446,146 - Daelken , et al. September 20, 2 | 2016-09-20 |
| Immunoconjugates targeting CD138 and uses thereof Grant 9,387,261 - Kraus , et al. July 12, 2 | 2016-07-12 |
| Agents Targeting Cd138 And Uses Thereof App 20160185854 - Kraus; Elmar ; et al. | 2016-06-30 |
| Method for treating psoriasis Grant 9,334,325 - Osterroth , et al. May 10, 2 | 2016-05-10 |
| Uses of immunoconjugates targeting CD138 Grant 9,289,509 - Osterroth , et al. March 22, 2 | 2016-03-22 |
| Agents targeting CD138 and uses thereof Grant 9,221,914 - Kraus , et al. December 29, 2 | 2015-12-29 |
| Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150218270 - OSTERROTH; Frank ; et al. | 2015-08-06 |
| Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates Grant 9,011,864 - Schulz , et al. April 21, 2 | 2015-04-21 |
| Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150064179 - OSTERROTH; FRANK ; et al. | 2015-03-05 |
| Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,956,607 - Osterroth , et al. February 17, 2 | 2015-02-17 |
| Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,852,871 - Osterroth , et al. October 7, 2 | 2014-10-07 |
| Uses Of Immunoconjugates Targeting Cd138 App 20140010828 - Schulz; Gregor ; et al. | 2014-01-09 |
| Agents For Treating Disease App 20130004513 - Osterroth; Frank ; et al. | 2013-01-03 |
| Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321617 - Osterroth; Frank ; et al. | 2012-12-20 |
| Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321618 - Osterroth; Frank ; et al. | 2012-12-20 |
| Composition For Treating Disease App 20110229465 - Osterroth; Frank ; et al. | 2011-09-22 |
| Uses Of Immunoconjugates Targeting Cd138 App 20110123554 - Osterroth; Frank ; et al. | 2011-05-26 |
| Agent For Treating Disease App 20110059082 - Germer; Matthias ; et al. | 2011-03-10 |
| Agent For Treating Disease App 20110059083 - AIGNER; SILKE ; et al. | 2011-03-10 |
| Agent For Treating Disease App 20110059084 - OSTERROTH; FRANK ; et al. | 2011-03-10 |
| Immunoconjugates Targeting Cd138 And Uses Thereof App 20090232810 - Kraus; Elmar ; et al. | 2009-09-17 |
| Method Of Decreasing Cytotoxic Side-effects And Improving Efficacy Of Immunoconjugates App 20090181038 - Schulz; Gregor ; et al. | 2009-07-16 |
| Agents Targeting Cd138 And Uses Thereof App 20090175863 - Kraus; Elmar ; et al. | 2009-07-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 